Skin Biopsy Indications and Technique for Adult Rash Evaluation

Pre‑Procedure Assessment

Document immunosuppression status on the pathology requisition because it influences differential diagnosis and treatment planning. 2
Record medication exposure within the prior two months when a drug‑induced rash is suspected, to guide diagnostic considerations. 3

For suspected immunobullous disease, obtain a lesional biopsy for routine histology and a separate perilesional biopsy taken within 1 cm of the active lesion for direct immunofluorescence, using Michel’s transport medium. 3
In cases of suspected cutaneous lymphoma that present with clinically normal skin, biopsy a trunk site even if the lesion appears normal, as lymphoma may be present despite lack of visible changes. 4

Use a 3–4 mm punch biopsy for inflammatory dermatoses; this yields full‑thickness tissue through the dermis into subcutaneous fat and is sufficient for most diagnostic purposes. 1
Perform a deep shave (saucerization) biopsy for raised inflammatory lesions, ensuring the specimen extends into the deep reticular dermis; superficial tangential shaves are inadequate. 1

Include precise anatomic location with laterality (e.g., “left forearm”) on the pathology request to aid accurate interpretation. [1][2]
Provide lesion duration and evolution pattern on the requisition to assist the pathologist in correlating clinical context. 2
For direct immunofluorescence studies, place the specimen in Michel’s transport medium or deliver fresh tissue to the laboratory within 24 hours. 3
If the biopsy shows tumor transection at the base, repeat the procedure with a deeper or alternative lesion, especially when melanoma or aggressive skin cancer is suspected. 1

Apply topical aluminum chloride 20–35 % or ferric subsulfate as first‑line hemostatic agents to minimize thermal artifact; these are preferred over routine electrocautery. (American Academy of Dermatology) 5
If topical agents do not achieve hemostasis, use light electrocautery limited to bleeding vessels only. (American Academy of Dermatology) 5